House Judiciary Targets Ex-Pfizer Executive With Subpoena

The chairman of the chamber, Jim Jordan, assigned Dr. Philip Dormitzer after refusing to testify in the probe delay in the 2020 vaccine, according to a letter.

Dormimitzer, former world chief of R&D, of Pfizer, refused to testify before the judicial committee of the Chamber through his lawyer, Susan Brune, according to Jordan’s letter. Brune informed the committee on May 29. Jordan assigned to sleep on Monday to appear before the committee on July 22 at 10:00 am. (Related: RFK Jr. appoints a fierce vaccination critic, Dr. Robert Malone, 7 others in the vaccination committee)

“The allegation according to which certain Pfizer employees worked to retain information on public health, apparently in order to influence the presidential election of 2020, implies significant federal interests and will require an additional investigation, which will in turn inform the potential legislative reforms,” ​​said a press release.

Brune has also reduced the scope of committee’s documents, claiming that his client had no reactive documents, but did not address the four categories requested, Jordan said.

“Instead, she wrote that” Pfizer representatives are or will be in communication … to provide the details you may request, “wrote the Congress member. (Related: the CDC manager who supervised Covid vaccine recommendations resigns in the middle of the RFK overhaul)

The committee had previously declared to Dormitzer that they had obtained information indicating that, between November 13 and 19, it communicated three times with a main legal framework in GSK, according to a letter of May 15. The three highest R&D officials of Pfizer have been connected to a decision to postpone clinical tests to prevent its completion before the results of the 2020 presidential elections.

“GSK also informed the committee that you were clearly that it was not a situation of delay in the disclosure of the results finished, but a situation of slowdown in the results before the disclosure became necessary. In particular, Ms. Brune’s response to the Committee did not dispute GSK’s main claims, including you have declared to a main legal framework in GSK that Pfizer had deliberately slowed down clinical tests so that it was not complete before the presidential election, “wrote Jordan.

Domitizer’s testimony is essential for monitoring the committee, and Brune’s response has not justified his inability to comply with the request, according to the letter

“In addition, Ms. Brune’s response did not address any of the four categories of documents specifically sought after by the Committee. Although Ms. Brune suggested that the committee could obtain other” details “from Pfizer, the committee’s request to Pfizer is separated and unique from the committee’s request,” continued Jordan (Related: Biden Admin has spent weeks “minimize” the vaccinated risks wearing before issuing a formal warning, according to the Senate report)

“Insofar as Pfizer has provided information to the Committee, it does not relieve you of your obligation to comply with the assistants that the Committee issues today.”

The president sent letters to Dormimitzer and CEO of Pfizer, Dr. Albert Bourla, on May 15, requesting their testimony after the reports fueled the allegations according to which Pfizer delayed the publication of its final phase 3 results and the announcement of efficiency of the vaccine until November 18, 2020 – 15 days after the election – to avoid helping the potential re -election of trump.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button